[ad_1]

In an August 1, 2019 Press Release, Healthcare Marijuana Inc., a U.S.-primarily based and publicly traded cannabis corporation announced that its subsidiary Kannaway, partnered with Endocanna Overall health, Inc., a analysis and improvement biotech corporation that specializes in endocannabinoid DNA testing and personalization. Endocanna, which is primarily based in California, specializes in genetic testing with DNA so that CBD customers may perhaps have a extra customized encounter.

According to the press release, the two firms will perform with each other to create and distribute endocannabinoid DNA test goods. The agreement offers that Endocanna will manage the manufacture of the patent-pending Endocannabinoid DNA Test Kits and license the technologies to Kannaway. Customers will be in a position to use the kits to establish customized information and other cannabinoids may perhaps interact with their body’s regulatory program. The agreement also provides Kannaway the chance to genetically aligned formulations by Endocanna into Kannaway goods.

Stuart Titus, Healthcare Marijuana Inc. CEO, shared in the press release,

“Our objective, in addition to supplying higher-top quality hemp-derived CBD goods, is to give our clients with education on which CBD goods may perhaps perform most effective for them. This partnership creates an chance for us to do this in an initial hyper-customized way and aid buyers find out how to incorporate CBD into their daily lives. We are extremely excited about our initially measures in this endeavor with Endocanna, but we also appreciate the development prospective of this partnership with the eventual objective of making customized dietary supplement goods to match one’s genetic typing and internal physique chemistry. We appear forward to making a lengthy-lasting partnership with Endocanna and enhancing final results for a diverse population, such as we have right here in the United States.”

Likewise, Len May perhaps, the CEO and Co-Founder of Endocanna shared in the press release,

“Our partnership with Kannaway offers an chance for us to perform with an business leader in building the most optimal goods though advancing the science about CBD. Making use of Endocanna Health’s proprietary DNA report, we can personalize and give a cannabinoid wellness protocol tailored to an individual’s requirements.”



[ad_2]